Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Ingevity price target lowered to $81 from $92 at Loop Capital » 08:57
11/18/21
11/18
08:57
11/18/21
08:57
NGVT

Ingevity

$79.00 /

+0.015 (+0.02%)

Loop Capital analyst…

Loop Capital analyst Christopher Kapsch lowered the firm's price target on Ingevity to $81 from $92 and keeps a Hold rating on the shares. The company's results are being negatively impacted by autobuild disruptions, even though its PC segment is performing well and its Q3 results were "very strong", the analyst tells investors in a research note. Kapsch adds that Ingevity's outlook remains clouded by the absence of visibility regarding both timing and magnitude of a more pronounced recovery in the key automotive end-market.

ShowHide Related Items >><<
NGVT Ingevity
$79.00 /

+0.015 (+0.02%)

NGVT Ingevity
$79.00 /

+0.015 (+0.02%)

07/29/21 Oppenheimer
Ingevity price target raised to $95 from $85 at Oppenheimer
05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
NGVT Ingevity
$79.00 /

+0.015 (+0.02%)

Over a month ago
Earnings
Ingevity backs FY21 revenue view $1.32B-$1.36B, consensus $1.35B » 16:27
10/27/21
10/27
16:27
10/27/21
16:27
NGVT

Ingevity

$76.41 /

-2.225 (-2.83%)

Cuts FY21 adjusted EBITDA…

Cuts FY21 adjusted EBITDA view to $405M-$420M from $425M-$440M.

ShowHide Related Items >><<
NGVT Ingevity
$76.41 /

-2.225 (-2.83%)

NGVT Ingevity
$76.41 /

-2.225 (-2.83%)

07/29/21 Oppenheimer
Ingevity price target raised to $95 from $85 at Oppenheimer
05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
NGVT Ingevity
$76.41 /

-2.225 (-2.83%)

Earnings
Ingevity reports Q3 adjusted EPS $1.62, consensus $1.50 » 16:26
10/27/21
10/27
16:26
10/27/21
16:26
NGVT

Ingevity

$76.41 /

-2.225 (-2.83%)

Reports Q3 revenue…

Reports Q3 revenue $376.8M, consensus $348.71M. "Our third quarter results were driven by markedly higher Performance Chemicals volumes in Engineered Polymers and Industrial Specialties and were supported by price increases across the segment," said John Fortson, president and CEO. "The prolonged impact of the global microchip shortage continues to depress automotive production, negatively impacting our activated carbon product sales. As a result, Performance Materials sales and adjusted EBITDA were down compared to 2020's third quarter when demand and production rebounded sharply from pandemic lows." Fortson also commented that the significant mix shift in total revenue, with Performance Chemicals up 38% and Performance Materials down 18%, drove the decline in consolidated margins.

ShowHide Related Items >><<
NGVT Ingevity
$76.41 /

-2.225 (-2.83%)

NGVT Ingevity
$76.41 /

-2.225 (-2.83%)

07/29/21 Oppenheimer
Ingevity price target raised to $95 from $85 at Oppenheimer
05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
NGVT Ingevity
$76.41 /

-2.225 (-2.83%)

Hot Stocks
Ingevity to challenge jury verdict on emissions control patent claim by BASF » 06:19
09/16/21
09/16
06:19
09/16/21
06:19
NGVT

Ingevity

$73.98 /

+0.085 (+0.12%)

, BASFY

BASF

$19.20 /

-0.09 (-0.47%)

Ingevity (NGVT) intends…

Ingevity (NGVT) intends to challenge a jury verdict rendered on Sept. 15 in the District Court in Delaware related to claims by BASF (BASFY) that Ingevity engaged in anticompetitive activities and interfered with an alleged prospective relationship between BASF and a customer. The claims relate to Ingevity's enforcement of its patent covering canister systems used in automotive gasoline vapor emissions control and the company's entry into several supply agreements with customers of its fuel vapor canister honeycombs. The jury ordered Ingevity to pay antitrust damages of approximately $28M, which will be automatically tripled under U.S. antitrust law to roughly $85M. Ingevity intends to pursue all legal relief available to challenge this outcome. Ingevity's '844 patent - set to expire in March 2022 - relates to certain canister systems designed to achieve gasoline vapor emissions levels that comply with EPA Tier 3 and California LEV III regulations. The verdict is not related to the manufacture of Ingevity's activated carbon. The company does not anticipate an immediate impact to commercial sales and is not aware of a competing certified or tested honeycomb that could replace sales of Ingevity's product immediately.

ShowHide Related Items >><<
NGVT Ingevity
$73.98 /

+0.085 (+0.12%)

BASFY BASF
$19.20 /

-0.09 (-0.47%)

NGVT Ingevity
$73.98 /

+0.085 (+0.12%)

07/29/21 Oppenheimer
Ingevity price target raised to $95 from $85 at Oppenheimer
05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
BASFY BASF
$19.20 /

-0.09 (-0.47%)

08/02/21 Barclays
BASF price target raised to EUR 77 from EUR 72 at Barclays
07/30/21 Berenberg
BASF price target lowered to EUR 72 from EUR 74 at Berenberg
07/30/21 Baader Helvea
BASF upgraded to Buy from Add at Baader Helvea
07/29/21 Credit Suisse
BASF price target raised to EUR 80 from EUR 79 at Credit Suisse
NGVT Ingevity
$73.98 /

+0.085 (+0.12%)

BASFY BASF
$19.20 /

-0.09 (-0.47%)

Over a quarter ago
Conference/Events
Ingevity to hold a conference call » 09:45
08/25/21
08/25
09:45
08/25/21
09:45
NGVT

Ingevity

$79.67 /

+0.26 (+0.33%)

Management discusses the…

Management discusses the outlook for the Pine Chemicals & Rosin Industry on a conference call to be held on August 25 at 10 am. Webcast Link

ShowHide Related Items >><<
NGVT Ingevity
$79.67 /

+0.26 (+0.33%)

NGVT Ingevity
$79.67 /

+0.26 (+0.33%)

07/29/21 Oppenheimer
Ingevity price target raised to $95 from $85 at Oppenheimer
05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
NGVT Ingevity
$79.67 /

+0.26 (+0.33%)

Conference/Events
Ingevity to hold a conference call » 04:55
08/25/21
08/25
04:55
08/25/21
04:55
NGVT

Ingevity

$79.36 /

+0.225 (+0.28%)

Management discusses the…

Management discusses the outlook for the Pine Chemicals & Rosin Industry on a conference call to be held on August 25 at 10 am. Webcast Link

ShowHide Related Items >><<
NGVT Ingevity
$79.36 /

+0.225 (+0.28%)

NGVT Ingevity
$79.36 /

+0.225 (+0.28%)

07/29/21 Oppenheimer
Ingevity price target raised to $95 from $85 at Oppenheimer
05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
NGVT Ingevity
$79.36 /

+0.225 (+0.28%)

Conference/Events
Ingevity to hold a conference call » 09:16
08/23/21
08/23
09:16
08/23/21
09:16
NGVT

Ingevity

$77.60 /

+0.24 (+0.31%)

Management discusses the…

Management discusses the outlook for the Pine Chemicals & Rosin Industry on a conference call to be held on August 25 at 10 am. Webcast Link

ShowHide Related Items >><<
NGVT Ingevity
$77.60 /

+0.24 (+0.31%)

NGVT Ingevity
$77.60 /

+0.24 (+0.31%)

07/29/21 Oppenheimer
Ingevity price target raised to $95 from $85 at Oppenheimer
05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
NGVT Ingevity
$77.60 /

+0.24 (+0.31%)

Recommendations
Ingevity price target raised to $95 from $85 at Oppenheimer » 07:27
07/29/21
07/29
07:27
07/29/21
07:27
NGVT

Ingevity

$83.27 /

+0.85 (+1.03%)

Oppenheimer analyst Ian…

Oppenheimer analyst Ian Zaffino raised the firm's price target on Ingevity to $95 from $85 and keeps an Outperform rating on the shares following quarterly results. The analyst highlights that driven by higher volumes and price increases across both Material and Chemicals, Q2 adjusted EBITDA of $117.7M beat his/Street's $109M/$108M. Revenues of $358M was also above his/Street's $334M/$338M, he adds.

ShowHide Related Items >><<
NGVT Ingevity
$83.27 /

+0.85 (+1.03%)

NGVT Ingevity
$83.27 /

+0.85 (+1.03%)

05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
02/08/21 Loop Capital
Ingevity downgraded to Hold from Buy at Loop Capital
NGVT Ingevity
$83.27 /

+0.85 (+1.03%)

Earnings
Ingevity raises FY21 revenue view to $1.32B-$1.36B from $1.275B-$1.325B » 16:21
07/28/21
07/28
16:21
07/28/21
16:21
NGVT

Ingevity

$83.27 /

+0.85 (+1.03%)

Consensus $1.33B. Raises…

Consensus $1.33B. Raises FY21 adjusted EBITDA view to $425M-$440M from $410M-$430M.

ShowHide Related Items >><<
NGVT Ingevity
$83.27 /

+0.85 (+1.03%)

NGVT Ingevity
$83.27 /

+0.85 (+1.03%)

05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
02/08/21 Loop Capital
Ingevity downgraded to Hold from Buy at Loop Capital
NGVT Ingevity
$83.27 /

+0.85 (+1.03%)

Earnings
Ingevity reports Q2 adjusted EPS $1.55, consensus $1.32 » 16:20
07/28/21
07/28
16:20
07/28/21
16:20
NGVT

Ingevity

$83.27 /

+0.85 (+1.03%)

Reports Q2 revenue…

Reports Q2 revenue $358.4M, consensus $337.64M. "Our strong second quarter financial results were driven by higher volumes and were supported by price increases across both segments," said John Fortson, president and CEO. "In Performance Materials, automotive-based activated carbon sales were up sharply compared to the second quarter of 2020 that was affected by industry shutdowns in North America and Europe, even though this quarter's results were tempered by the ongoing negative impact of the global microchip shortage. In Performance Chemicals, we saw significant growth across all businesses."

ShowHide Related Items >><<
NGVT Ingevity
$83.27 /

+0.85 (+1.03%)

NGVT Ingevity
$83.27 /

+0.85 (+1.03%)

05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
02/08/21 Loop Capital
Ingevity downgraded to Hold from Buy at Loop Capital
NGVT Ingevity
$83.27 /

+0.85 (+1.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.